Results of a Feasibility and Phase II Study on Bortezomib (BTZ) in Pediatric Multiply Relapsed or Refractory Acute Lymphoblastic Leukemia: Complete Hematological Responses with a Modestly Intensive Regimen Including BTZ

Affiliation auteurs!!!! Error affiliation !!!!
TitreResults of a Feasibility and Phase II Study on Bortezomib (BTZ) in Pediatric Multiply Relapsed or Refractory Acute Lymphoblastic Leukemia: Complete Hematological Responses with a Modestly Intensive Regimen Including BTZ
Type de publicationJournal Article
Year of Publication2014
AuteursKaspers G, Niewerth D, Ramnarain S, Attarbaschi A, Baruchel A, De Bont ES, Fagioli F, De Moerloose B, Nysom K, Palumbo G, Reinhardt D, Rohrlich P-S, Simon P, von Stackelberg A, C. Zwaan M
JournalBLOOD
Volume124
Date PublishedDEC 6
Type of ArticleMeeting Abstract
ISSN0006-4971